Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension
Clinical trial NCT00344110 · COMPLETED
Trial details
- NCT number
- NCT00344110
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2007-04-01
- Enrollment
- 768
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.